MIR7108

microRNA 7108, the group of MicroRNAs

Basic information

Region (hg38): 19:2434914-2435000

Links

ENSG00000283728 ∙ NCBI:102466806 ∙ ∙ HGNC:49998 ∙ ∙ ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MIR7108 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MIR7108 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous						0
missense						0
nonsense						0
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region						0
non coding						0
Total	0	0	0	0	0

Variants in MIR7108

This is a list of pathogenic ClinVar variants found in the MIR7108 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
19-2434919-G-A		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jun 15, 2024)
19-2434921-G-A		Lipodystrophy, partial, acquired, susceptibility to;Progressive myoclonic epilepsy type 9	Likely benign (Oct 22, 2024)
19-2434923-G-A		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Apr 03, 2024)
19-2434925-C-T		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Apr 07, 2024)
19-2434925-CG-C		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Oct 16, 2024)
19-2434926-G-A		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Jul 03, 2024)
19-2434927-G-C		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Benign (Jan 19, 2025)
19-2434929-C-T		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Nov 28, 2024)
19-2434930-G-A		Lipodystrophy, partial, acquired, susceptibility to;Progressive myoclonic epilepsy type 9	Likely benign (Dec 16, 2020)
19-2434943-C-T			Benign (Jun 19, 2021)
19-2434985-C-T		Lipodystrophy, partial, acquired, susceptibility to;Progressive myoclonic epilepsy type 9	Likely benign (Feb 13, 2024)
19-2434986-G-A		Lipodystrophy, partial, acquired, susceptibility to;Progressive myoclonic epilepsy type 9	Uncertain significance (Oct 17, 2022)
19-2434987-C-T		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to	Likely benign (Dec 26, 2020)
19-2434990-G-T		not specified	Likely benign (Jun 21, 2024)
19-2434992-C-A		Lipodystrophy, partial, acquired, susceptibility to;Progressive myoclonic epilepsy type 9	Likely benign (Aug 27, 2020)
19-2434993-G-A		Progressive myoclonic epilepsy type 9;Lipodystrophy, partial, acquired, susceptibility to • not specified • LMNB2-related disorder	Benign/Likely benign (Jan 27, 2025)

GnomAD

Source: gnomAD

dbNSFP

Source: dbNSFP